Page last updated: 2024-08-23

metergoline and fluvoxamine

metergoline has been researched along with fluvoxamine in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adkison, KK; Humphreys, JE; Mahar Doan, KM; Polli, JW; Serabjit-Singh, CJ; Shampine, LJ; Webster, LO; Wring, SA1
Horiuchi, H; Morino, T; Ogata, T; Takeba, J; Yamamoto, H1

Other Studies

2 other study(ies) available for metergoline and fluvoxamine

ArticleYear
Passive permeability and P-glycoprotein-mediated efflux differentiate central nervous system (CNS) and non-CNS marketed drugs.
    The Journal of pharmacology and experimental therapeutics, 2002, Volume: 303, Issue:3

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood-Brain Barrier; Cell Line; Cell Membrane Permeability; Central Nervous System Agents; Dogs; Drug Delivery Systems; Permeability; Pharmaceutical Preparations

2002
Serotonergic signaling inhibits hyperalgesia induced by spinal cord damage.
    Brain research, 2003, Feb-14, Volume: 963, Issue:1-2

    Topics: Animals; Brain Stem; Female; Fluvoxamine; Hot Temperature; Hyperalgesia; Metergoline; Nociceptors; Pain Measurement; Physical Stimulation; Rats; Rats, Wistar; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Signal Transduction; Spinal Cord; Spinal Cord Compression; Spinal Cord Injuries

2003